Literature DB >> 7381854

Structure--antitubulin activity relationship in steganacin congeners and analogues. Inhibition of tubulin polymerization in vitro by (+/-)-isodeoxypodophyllotoxin.

F Zavala, D Guenard, J P Robin, E Brown.   

Abstract

A new series of 23 synthetic analogues of the naturally occurring antitumor lignan steganacin was tested for the inhibition of microtubule assembly in vitro. Interestingly, (+/-)-isopicrostegane (I50 = 5 microM) was found to be almost as active as (+/-)-steganacin(I50 = 3.5 microM). On the other hand, racemic isodeoxypodophyllotoxin has an inhibiting activity of microtubule assembly comparable to that of (-)-podophyllotoxin, whereas (-)-isodeoxypodophyllotoxin is totally inactive.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7381854     DOI: 10.1021/jm00179a014

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  4 in total

1.  Flavonoid-induced morphological modifications of endothelial cells through microtubule stabilization.

Authors:  Yasmine S Touil; Arlette Fellous; Daniel Scherman; Guy G Chabot
Journal:  Nutr Cancer       Date:  2009       Impact factor: 2.900

2.  Potent antiproliferative cembrenoids accumulate in tobacco upon infection with Rhodococcus fascians and trigger unusual microtubule dynamics in human glioblastoma cells.

Authors:  Aminata P Nacoulma; Veronique Megalizzi; Laurent R Pottier; Manuela De Lorenzi; Sylviane Thoret; Joëlle Dubois; Olivier M Vandeputte; Pierre Duez; Danny Vereecke; Mondher El Jaziri
Journal:  PLoS One       Date:  2013-10-22       Impact factor: 3.240

3.  Total Synthesis of Lignan Lactone (-)-Hinokinin.

Authors:  Qi-Long Zhou; Hui-Jing Wang; Pei Tang; Hao Song; Yong Qin
Journal:  Nat Prod Bioprospect       Date:  2015-10-12

4.  Synthesis and Antiproliferative Activity of Novel Heterocyclic Indole-Trimethoxyphenyl Conjugates.

Authors:  Michael M Cahill; Kevin D O'Shea; Larry T Pierce; Hannah J Winfield; Kevin S Eccles; Simon E Lawrence; Florence O McCarthy
Journal:  Pharmaceuticals (Basel)       Date:  2017-07-05
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.